Cargando…
AGAP2-AS1 as a prognostic biomarker in low-risk clear cell renal cell carcinoma patients with progressing disease
BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is the most common subtype of renal cancer and one of the most common cancers. While survival for localized ccRCC is good, the survival of metastatic disease is not, and thirty percent of patients with ccRCC develop metastases during follow-up. Alt...
Autores principales: | Nakken, Sigrid, Eikrem, Øystein, Marti, Hans-Peter, Beisland, Christian, Bostad, Leif, Scherer, Andreas, Flatberg, Arnar, Beisvag, Vidar, Skandalou, Eleni, Furriol, Jessica, Strauss, Philipp |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686242/ https://www.ncbi.nlm.nih.gov/pubmed/34930263 http://dx.doi.org/10.1186/s12935-021-02395-9 |
Ejemplares similares
-
A multiomics disease progression signature of low-risk ccRCC
por: Strauss, Philipp, et al.
Publicado: (2022) -
Transcriptome Sequencing (RNAseq) Enables Utilization of Formalin-Fixed, Paraffin-Embedded Biopsies with Clear Cell Renal Cell Carcinoma for Exploration of Disease Biology and Biomarker Development
por: Eikrem, Oystein, et al.
Publicado: (2016) -
Expanding the Utilization of Formalin-Fixed, Paraffin-Embedded Archives: Feasibility of miR-Seq for Disease Exploration and Biomarker Development from Biopsies with Clear Cell Renal Cell Carcinoma
por: Strauss, Philipp, et al.
Publicado: (2018) -
Fine needle aspirates of kidneys: a promising tool for RNA sequencing in native and transplanted kidneys
por: Eikrem, Øystein, et al.
Publicado: (2018) -
Proteomic analysis unveils Gb3-independent alterations and mitochondrial dysfunction in a gla(−/−) zebrafish model of Fabry disease
por: Elsaid, Hassan Osman Alhassan, et al.
Publicado: (2023)